Situation:
An emerging specialty biopharma company in rapid acquisition mode had skill gaps at several levels over a multi-year period, including senior clinical leadership, outcomes research, and clinical quality assurance positions.
Solutions:
- Interim leadership of several different complex international programs was undertaken until adequate replacements could be identified. Upon identification, Halloran effected seamless transition and historical support to continue execution on critical timelines.
- Provided leadership, mentoring, and coaching of a number of junior clinical team members to augment skill gaps, which enabled continuation of critical programs.
- Implemented project management across the entire organization.
- Provided interim senior level clinical quality leadership to backfill a senior position due to a reorganization.
- Re-engineered processes, procedures, roles, and responsibilities throughout development.
- Designed and delivered multiple training programs throughout the organization.
- Integrated all aspects of acquisition programs, including adjustment of regulatory strategy, assumption of CSRs, and transfer of data from completed studies.
Value:
The company exploited an opportunity to take over lucrative market share on an orphan indication and moved quickly to acquire, integrate, and maximize value of acquisitions while growing rapidly, and simultaneously augmenting infrastructure and skills of an immature clinical team.